China · Delayed Price · Currency is CNY Harbin Medisan Pharmaceutical Company Description
Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale chemical pharmaceutical preparations in China.
The company offers various drugs for nervous system, cardiovascular system, systemic anti-infective, muscle and skeletal system, nutritional infusion, and body fluid balance infusion; and other products, including oxaliplatin for injection, calcium folinate for injection, hydroxylcamptothecine injection, tropisetron hydrochloride for injection, tropisetron hydrochloride and glucose injection, gabexate mesylate for injection, bismuth potassium citrate granules, pantoprazole sodium for injection, ambroxol hydrochloride and glucose injection, asarone for injection, paracetamol and tramadol hydrochloride tablets, rifamycin sodium for injection, lornoxicam for injection, vecuronium bromide for injection, and vitamin c for injection.
It also provides medical devices and cosmetics. Harbin Medisan Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Harbin, China.
| Country | China |
| Founded | 1996 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,522 |
| CEO | Jian Fei Qin |
Contact Details
Address: The middle part of Beijing Road Harbin, 150025 China | |
| Phone | 86 451 8560 8888 |
| Website | medisan.com.cn |
Stock Details
| Ticker Symbol | 002900 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000032V9 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jian Fei Qin | Chairman and President |
| Zhicheng Zhao | Financial Director |
| Yan Fei Liang | Vice President, Board Secretary and Director |
| Xia Li | Accounting Supervisor |